🇺🇸 Radioimmunotherapy in United States
3 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 3
Most-reported reactions
- Neutrophil Count Decreased — 1 report (33.33%)
- Platelet Count Decreased — 1 report (33.33%)
- White Blood Cell Count Decreased — 1 report (33.33%)
Other Immunology approved in United States
Frequently asked questions
Is Radioimmunotherapy approved in United States?
Radioimmunotherapy does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Radioimmunotherapy in United States?
University Hospital Tuebingen is the originator. The local marketing authorisation holder may differ — check the official source linked above.